These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2534268)

  • 1. [The heart in patients with hypertension: effects of rilmenidine on experimental cardiac hypertrophy of hypertensive origin in rats].
    Callens-el Amrani F; Paolaggi F; Swynghedauw B
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():53-7. PubMed ID: 2534268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remodelling of the heart in DOCA-salt hypertensive rats by propranolol and by an alpha-2 agonist, rilmenidine.
    Callens-el Amrani F; Paolaggi F; Swynghedauw B
    J Hypertens; 1989 Dec; 7(12):947-54. PubMed ID: 2576430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Remission of left ventricular hypertrophy of hypertensive origin. Experimental data].
    Contard F; Rappaport L; Samuel JL; Swynghedauw B
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():27-30. PubMed ID: 2150472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial function structure and collagen in the spontaneously hypertensive rat: progression from compensated hypertrophy to haemodynamic impairment.
    Bing OH; Sen S; Conrad CH; Brooks WW
    Eur Heart J; 1984 Dec; 5 Suppl F():43-52. PubMed ID: 6241902
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of manidipine on cardiac hypertrophy and coronary circulation in DOCA/salt hypertensive rats.
    Takeda K; Nakata T; Kuwabara T; Itoh H; Yamahara Y; Takesako T; Tanabe S; Sasaki S; Asayama J; Nakagawa M
    Blood Press Suppl; 1992; 3():48-52. PubMed ID: 1343289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pump performance after regression of cardiac hypertrophy following treatment of hypertension with isradipine.
    Saragoça MA; de Almeida JB; Amorim MP; Portela J; Cezaretti ML; Ramos OL
    J Hypertens Suppl; 1989 Dec; 7(6):S288-9. PubMed ID: 2534415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular compliance in the DOCA-salt model of hypertension in the rat. Effects of propranolol.
    Cheav SL; Delcayre C; Besnard JC; Paolaggi F; Mouas C; Swynghedauw B
    Arch Int Pharmacodyn Ther; 1991; 314():5-24. PubMed ID: 1840461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of cardiac hypertrophy. Experimental animal model.
    Sen S
    Am J Med; 1983 Sep; 75(3A):87-93. PubMed ID: 6137950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antihypertensive agent cicletanine reverses vascular hyperreactivity to noradrenaline and cardiac hypertrophy in DOCA-salt rats.
    Castro A; Parra L; Alsasua A; Fuentes JA
    Arch Int Pharmacodyn Ther; 1990; 307():109-18. PubMed ID: 2151359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac hypertrophy and failure in hypertension.
    Johnson DB; Dell'Italia LJ
    Curr Opin Nephrol Hypertens; 1996 Mar; 5(2):186-91. PubMed ID: 8744544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac hypertrophy in hypertension].
    Yamasaki H; Kaku T; Ueda K
    Nihon Rinsho; 1992 May; 50 Suppl():400-5. PubMed ID: 1387425
    [No Abstract]   [Full Text] [Related]  

  • 14. Sympatho-adrenal mechanisms regulating cardiovascular hypertrophy in primary hypertension: a role for rilmenidine?
    Bobik A; Dilley R; Kanellakis P
    J Hypertens Suppl; 1998 Aug; 16(3):S51-4. PubMed ID: 9747911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenergic activity and myocardial anatomy and function in essential hypertension.
    Muiesan G; Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1985 Dec; 3(4):S45-50. PubMed ID: 3007705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension in general practice. Part III. Treatment of hypertensive heart failure and hypertensive emergencies.
    Opie LH
    S Afr Med J; 1980 Dec; 58(26):1025-9. PubMed ID: 6450463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antihypertensive therapy upon myosin isozyme distribution in spontaneously hypertensive rats.
    Sen S; Young D
    J Hypertens; 1992 Aug; 10(8):749-56. PubMed ID: 1325506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial hypertrophy and cardiac failure: a complex interrelationship.
    Massie BM
    Am J Med; 1983 Sep; 75(3A):67-74. PubMed ID: 6226198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial response to stress in cardiac hypertrophy and heart failure: effect of antihypertensive drugs.
    Sen S
    Ann N Y Acad Sci; 1999 Jun; 874():125-33. PubMed ID: 10415526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension and age-related changes in the heart. Implications for drug therapy.
    Isoyama S
    Drugs Aging; 1994 Aug; 5(2):102-15. PubMed ID: 7981482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.